CTSO·23283X206·US·equity·Healthcare - Medical Devices-13D/G
CTSO (CYTOSORBENTS CORP) is held by 34 institutional investors as of Q1 2026. Largest holders: Neuberger Berman Group LLC ($950,776), BlackRock, Inc. ($443,408), GEODE CAPITAL MANAGEMENT, LLC ($400,621). Net institutional sentiment: Mixed.
See how CTSO's score breaks down across 4 SEC sources
Showing 1-20 of 37
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer